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Abstract
Background: Non-communicable diseases (NCDs) result in more deaths globally
than other causes. Monitoring systems require strengthening to attribute the NCD
burden and deaths in low and middle-income countries (LMICs). Data from health
and demographic surveillance systems (HDSS) can contribute towards this goal.
Methods and Findings: Between 2003 and 2010, 15,228 deaths in adults aged 15
years (y) and older were identified retrospectively using the HDSS census and
verbal autopsy in rural western Kenya, attributed into broad categories using
InterVA-4 computer algorithms; 37% were ascribed to NCDs, 60% to
communicable diseases (CDs), 3% to injuries, and ,1% maternal causes. Median
age at death for NCDs was 66y and 71y for females and males, respectively, with
43% (39% male, 48% female) of NCD deaths occurring prematurely among adults
aged below 65y. NCD deaths were mainly attributed to cancers (35%) and cardio-
vascular diseases (CVDs; 29%). The proportionate mortality from NCDs rose from
35% in 2003 to 45% in 2010 (x2 linear trend 93.4; p,0.001). While overall annual
mortality rates (MRs) for NCDs fell, cancer-specific MRs rose from 200 to 262 per
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100,000 population, mainly due to increasing deaths in adults aged 65y and older,
and to respiratory neoplasms in all age groups. The substantial fall in CD MRs
resulted in similar MRs for CDs and NCDs among all adult females by 2010. NCD
MRs for adults aged 15y to ,65y fell from 409 to 183 per 100,000 among females
and from 517 to 283 per 100,000 population among males. NCD MRs were higher
among males than females aged both below, and at or above, 65y.
Conclusions: NCDs constitute a significant proportion of deaths in rural western
Kenya. Evidence of the increasing contribution of NCDs to overall mortality
supports international recommendations to introduce or enhance prevention,
screening, diagnosis and treatment programmes in LMICs.
Introduction
Non-communicable diseases (NCDs) are reported to be responsible for two out of
every three deaths worldwide [1]; of 36 m deaths associated with NCDs globally,
80% occur in low- and middle-income countries (LMICs) [2–4]. NCD deaths are
mainly due to cardiovascular diseases (CVDs), cancers, chronic respiratory
diseases and diabetes [3,5,6]; other major causes of NCD mortality include suicide
and injury related to depressive disorders, maternal deaths, and road injuries [7].
Ischaemic heart disease is the leading cause of premature mortality worldwide [1].
Globally the proportion of NCD deaths are predicted to rise from 59% in 2002 to
69% of all deaths by 2030 [7]. The relative increase in the NCDs burden has been
classified as a global crisis and a barrier to development goals around poverty
reduction, health equity, economic stability, and human security [8]. Recent data
suggest health care is restricted to hospital level services only [9], and poor access
to appropriate care resulting in low survival [10]. A lack of interventions will
result in a cumulative economic loss surpassing US$7 trillion in LMICs between
2011–2025 [11]. However, increases in the proportion of deaths due to NCDs also
reflects improved life expectancy, increasing exposure to risk factors of NCDs,
both due to increasing longevity and to societal changes, including for example,
tobacco promotion [4]. The proportional increase in NCD deaths is also a result
of reducing CD burden, reflecting improvements in population health. It is
expected that as the disposable income of LMIC rises, risk factors for NCD
disorders such as cardiovascular diseases will increase in tandem, while an on-
going heavy CDs burden will continue [12]. Interventions are needed to address
the growing burden of NCDs in African countries [2,4,5,13–15]. Evidence of the
cause-specific burden of NCDs is required to plan and fund such interventions,
but such data do not exist in many counties [16–18], and concerns have been
raised on the quality of data available for interpreting trends [19].
Areas in sub-Saharan Africa (SSA) with potential to monitor changing trends in
causes of death over time can contribute towards global knowledge on disease
burdens of LMICs [5,6]. A health and demographic surveillance system (HDSS) in
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western Kenya, established through the Kenyan Medical Research Institute
(KEMRI) in collaboration with the US Centers for Disease Control and
Prevention (CDC) provides such an opportunity [20]. Longitudinal studies on
mortality associated with HIV [21], TB [22], maternal [23], trauma [24], and
deaths among children [25], and adolescent and young adults [26], have been
characterised. This paper aims to examine NCDs mortality patterns over a similar
timespan in order to evaluate the contribution of NCDs to all adult deaths and
identify trends for attributed causes.
Materials and Methods
Study site and population
The HDSS study site is located in a rural part of Siaya County, in western Kenya
[20,27]. The area consists of 385 villages spread over a 700 km2 area along the
shores of Lake Victoria, with a population in 2010 of 224,500 adults in aged 15
years (y) and above. The population, mainly subsistence farmers, are almost
exclusively members of the Luo ethnic group and traditionally polygynous, have
been described in detail elsewhere [20,28].
Health and Demographic Surveillance System
The HDSS is a population-based system with GPS locational data, that
longitudinally records demographic (births, deaths, pregnancies, and in- and out-
migrations) information [20]. Household census among the population takes
place tri-annually, in January-March, May-August, and October-December, by
field staff who visit all households in the study site.
Verbal autopsy (VA)
Verbal autopsy is conducted in subpopulations covered by HDSS. All deaths in
residents, defined as having resided in the area for at least four consecutive
months, are identified by local village reporters through ongoing local
monitoring, and are validated during the tri-annual census. At least one month
following death, and within four months to reduce recall bias, an interviewer
returns to the home and records events surrounding the death, using standardized
WHO verbal autopsy (VA) questionnaires endorsed by the INDEPTH Network
[20,29,30], with spouses or another close relative of the deceased. Resident
identification numbers allow linkage of each death with HDSS data. In this paper,
cause of death was attributed using the InterVA-4 methodology, a new public-
domain probabilistic model for interpreting cause of death from VA data [31,32].
This methodology attributes cause of death compatible with the International
Classification of Diseases 10 (ICD-10) categorised into 62 overall groups through
a computer simulated algorithm. ICD-10 codes and the respective VA coding and
disease categories are listed in Table S1. Indicators required to run the InterVA-4
Model were extracted from VA data and entered into the model to generate cause
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of death. The model produces a maximum of three probable causes of death and
their corresponding likelihoods. In this paper, analyses focus on primary cause of
deaths since only 10% received a secondary and,1% received a tertiary diagnosis.
The model has a built-in facility to adjust for the prevalence of malaria and HIV/
AIDS. Before running, the model was set high for both the diseases. Previous
studies in our surveillance area have reported the prevalence of malaria and HIV/
AIDs at 33% and 14% respectively [20,21,25].
Ethical considerations
The HDSS protocol and consent procedures, including surveillance and VA, are
approved by the Ethical Review Committee of the Kenyan Medical Research
Institute (#1801) and by the Centers for Disease Control and Prevention
Institutional Review Board (#3308). Following cultural customs, compound
heads provide written informed consent for all compound members to participate
in HDSS activities. Individuals can refuse to participate at any time. All HDSS
census and VA data are maintained on a secure server accessed by authorized
researchers only. Named data are securely stored in a MS-SQL database and only
authorized data personnel have access rights. Datasets analysed by scientists are
stripped of names to protect identity.
Analyses
For this evaluation, adults were defined as persons aged 15 years and older. Data
were extracted from the HDSS database for all adult deaths in residents, generated
from the adult VA questionnaire, between January 2003 and December 2010.
Primary cause was derived from aggregated ICD-10 codes generated by the
InterVA-4 algorithms [31] (Table S1). Median age of death is presented with
interquartile ranges (IQR), for grouped causes of NCD deaths. Analyses are
stratified by sex, and into two age groups, using 65 years as the break-point (i.e.
below; 15y to ,65y, and at or above; >65y), to investigate trends in the causes
and proportion of premature (aged below 65y) NCD deaths. Descriptive data
include deaths in Karemo villages captured 2008–2010, but time trends on the
absolute number of deaths and mortality rates 2003–2010 exclude these villages.
Mortality rates per 100,000 population for CDs and NCDs, and for main NCD
causes (as aggregated through ICD-10 codes; Table S1), were estimated by year
and age category using mid-year population-point estimates generated from the
HDSS census. The age-sex structure of the adult population was examined per
year to clarify if relative proportions changed over time. The highly stable
population profile precluded the need to make temporal adjustments to the
denominator for analysis of rates.
Key social and demographic characteristics generated from questioning the
compound head during HDSS census surveys were examined, to compare
differences among deaths from NCD and CD, and by sex. This included marital
status (ever married, married at time of death, divorced), education (completed
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primary, secondary school), and socio-economic status (SES). SES quintiles were
based on multiple correspondence analysis (MCA) generated from biennial
surveys on wealth indicators, reported elsewhere [20,26]. In this paper we
collapsed the five SES quintiles into two, portraying poorest (lowest two quintiles)
and less poor (highest three quintiles).
Analyses were conducted using SPSS for Windows (Release v21.0; IBM,
Endicott, NY, USA), and EpiInfo Stat Calc (v7; CDC Atlanta, USA). Chi-squared
(x2) test for linear trend (LT) determined the significance of changing rates by sex
and age over time (2003 to 2010). Pearson’s x2 test was used to determine
differences between groups. Mantel Haenszel Relative Risks (RR), with Taylor
Series 95% confidence intervals (CI), were used to compare annual mortality rates
between sexes. We stratified RR analyses for mortality rates by age groups, sex,
and year generating a summary x2, with a Mantel Haenszel weighted RR (MHRR)
and Greenlands-Robins 95% CI. Significance was set at 5% or less.
Results
Relative contribution of NCD deaths
Between 2003 and 2010, 15,228 deaths were recorded in persons living in the
HDSS aged 15 years and older. Of these, 13,293 (87%) had a defined primary
cause of death, and 1,935 (13%, 957 males, 978 females) were of indeterminate or
unknown cause. Figure 1 illustrates primary cause of death for females and males;
52% (54% females, 52% males) were attributed to CDs; 32% (31% females, 33%
males) to NCDs, 3% (2% females, 3% males) to injury, ,1% (1% females) to
maternal causes, and 13% (12% females, 13% males) were indeterminate.
Pregnancy- and injury-related deaths are described in detail elsewhere [23,24].
Of the 12,808 adult NCD and CD deaths, two-thirds were 15y to ,65y of age,
among both female and male deaths. The median age at death among females was
significantly lower than males for CD causes, and significantly higher for NCD
causes (Figure 2).
Of 11,112 CD and NCD deaths (excluding Karemo) recorded between 2003 and
2010, the overall number of deaths fell by 35% from 1,550 in 2003 to 1,003 in 2010
(Figure 3). While the number of CD deaths dropped 45% (41% males, 49%
females) the number of NCD deaths fell 15% (20% males, 10% females). Thus,
the proportion of deaths with a primary NCD cause rose over the eight years from
35% to 45% (x2 LT 93.4; p,0.001) of all deaths. This trend was consistent for
both sexes (Figure 3). Distribution of deaths stratified by an age threshold of 65y
found the proportion of NCD to CD deaths in adults aged ,65y varied by year
within a range of 20–30%, with a weak trend for an increasing percentage of
NCDs over time (Figure 3). Among deaths of persons aged >65y there was a
significant increase in the percentage of NCD deaths, rising from 55% in 2003 to
68% in 2010 (x2 LT 30.5, p,0.001), evident in both sexes (Figure 3).
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Characteristics of Deaths
Among the 12,808 deaths, there was no difference in marital status between NCD
and CD with nearly all (93%) ever married, and half married at the time of death;
however, divorce (separation) was almost twice among CD compared with NCD
deaths (9% v 17% v 9% RR 1.8; 95% CI 1.6–2.1). Half of persons who had died
were in the poorer socio-economic status (SES) two quintiles, with NCD
marginally higher (50%) compared with CD (46%). A significantly higher
proportion of deaths of persons from CD completed primary school compared
with NCD (37% v 19%; p,0.001). Less than 1% of NCD and CD deaths
completed secondary schooling. Differences by sex were noted for the proportion
in the lowest two SES quintiles with females significantly poorer among NCD
compared with CD (59% v 50%, p,0.001), but not among males (NCD and CD,
42%). Differences between NCD and CD for schooling held for both sexes.
Married at time of death reversed for males and females; thus while 70% of male
Figure 1. Causes of deaths among all adults aged 15 years and above, rural western Kenya, 2003–2010. A. Female Deaths. B. Male Deaths.
doi:10.1371/journal.pone.0114010.g001
Figure 2. Comparison of median ages at death between CDs and NCDs by sex. A. All Deaths. B. Deaths ,65y.
doi:10.1371/journal.pone.0114010.g002
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NCD deaths were married (compared with 64% of CD), among females 31% of
NCD were married and 36% of CD, illustrating the high proportion of female
deaths, particularly from NCDs, occurring in widowhood.
NCDs as primary causes of death
Among the 4,847 NCD-attributed deaths, two-thirds were ascribed to cancers and
CVDs (Figure 4). For males and females combined, cancers were the leading
primary cause responsible for 35% of NCD deaths, CVDs were second most
common (29%), and abdominal disorders third (16%). Five percent of deaths
were each recorded as due to pulmonary, metabolic disorders, renal diseases, and
epilepsy, with a further 8% attributed to other NCDs.
Tables S2-S5 list details of 4,107 deaths by study year and thus exclude 740
deaths from Karemo, overall (Table S2, Figure S1), and by type, age threshold, and
sex. Figures S1-S9 graphically illustrate these data.
Cancers
Digestive, respiratory/intrathoracic, reproductive, female breast, oral, and other/
unspecified (all area total of 1,702 deaths; 854 [50%] male, 848 female). Deaths
attributed to neoplasms were distributed equally between males and females. The
median age of death for all cancers was 66y (IQR 48-77; Figure 5). Close to half
(48%) of deaths were ,65y of age. A higher proportion of male cancer deaths
were ,65y compared with female (52% v 43%, x2 13.7, p,0.001).
Among 1,410 cancer deaths assessed for trends over time (excluding Karemo),
the annual number of cancer deaths rose 41% from 150 to 212 deaths between
2003 and 2010 (Table S2, Figure S2). This increased the relative contribution of
cancers to all NCD deaths from 26% to 45% (x2 LT 56; p,0.001). This was due to
a sharp rise in deaths attributed to neoplasms among persons >65y rising nearly
3-fold, and more than doubling the overall contribution of cancers to NCD deaths
among older adults by 2010 (x2 LT 52.9, p,0.001). Among deaths in adults aged
,65y, the number of cancer deaths ascribed fell slightly over time, but due to
Figure 3. Trends in absolute number of adult deaths attributed to CD and NCD causes in western Kenya, 2003–2010. A. All Deaths. B. Deaths,65y.
C. Deaths >65y.
doi:10.1371/journal.pone.0114010.g003
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steep reductions in other NCD deaths in adults aged,65y, the relative proportion
of cancers against all NCDs increased in this younger age group, most notably
among females ,65y. The interVA-4 computer algorithm allocated cancers into
five broad neoplasms: digestive, respiratory, male and female reproductive, oral,
female breast, and other or unspecified.
(i) Digestive neoplasms (501 deaths): This included carcinomas of the
oesophagus, gut, and liver and constituted 29% of all attributed cancers.
The median age at death for digestive neoplasms was 62y (IQR 49-75), with
55% of deaths occurring among adults ,65y of age. While the overall
number and proportion of deaths from neoplasms classified as digestive did
not change over time, there was a decrease in deaths in adults ,65y dying
from digestive neoplasms, with a concomitant increase among persons who
died aged >65y.
(ii) Respiratory/intrathoracic neoplasms (460 deaths): This includes carcinomas
of the trachea, bronchus and lung; thymus; heart, mediastinum and pleura,
and other/ill-defined respiratory and intrathoracic sites. These represented
Figure 4. Causes of NCDs deaths among adults in rural western Kenya, 2003–2010. A. Female NCD Deaths. B. Male NCD Deaths.
doi:10.1371/journal.pone.0114010.g004
Figure 5. Comparison of median ages of adult deaths by sex, for different NCD causes in rural western Kenya. A. All Deaths. B. Deaths ,65y.
doi:10.1371/journal.pone.0114010.g005
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27% of all fatal cancers. The median age at death for respiratory/
intrathoracic neoplasms was 70y (IQR 53-79), with 39% of deaths occurring
in persons ,65y of age. The annual number of deaths ascribed to
respiratory cancers rose from 5% to 50% of all attributed cancers. In adults
aged ,65y, both the proportion and the absolute number of deaths from
respiratory/intrathoracic neoplasms rose significantly (x2 LT: males 57.1,
p,0.001; females 42.8, p,0.001). Significant linear trends were also
observed among both sexes for such deaths in persons aged >65y.
(iii) Reproductive neoplasms (97 deaths): In females, these include vulva, vagina,
cervix uteri, corpus uteri, uterus, ovary, and other/unspecified genital sites.
In males this category includes penis, prostate, testis, and other/unspecified
genital sites. These neoplasms contributed 6% of all fatal cancers, 2% of
male cancer deaths and 10% of female deaths. The median age at death for
reproductive neoplasms was 65y (IQR 44-76), with 50% (31% male, 53%
female) ,65y of age.
(iv) Female breast neoplasm (20 deaths): This was recorded as the cause of 2% of
female cancer deaths with no reported deaths among males. The median age
at death for female breast cancer was young - 41y (IQR 31-47); 85% of
female breast cancer deaths were reported among females ,65y of age.
(v) Oral neoplasms (33 deaths): This category includes neoplasms of the
tongue, gum, floor of the mouth, palate and other/unspecified sites of the
mouth. These contributed 2% of all cancers, 2% for each sex. The median
age at death for oral neoplasms was 47y (IQR 34-71) with 67% (63% of
male, 71% of female) of deaths occurring among persons ,65y of age.
(vi) Other or unspecified neoplasms (591 deaths): This large group aggregates a
broad range of sub-categories including Kaposi sarcomas, neoplasms of the
urinary tract, brain, thyroid and other endocrine glands. These were
reported in 35% of all cancers. The median age at death for other/
unspecified neoplasms was 67y (IQR 48-78), with 46% below 65y of age.
Males died at a younger age than females with a median age of 57y (IQR 39-
74), compared with 73y (IQR 60-81), respectively. The proportion and
absolute number of deaths attributed to these neoplasms reduced over time,
for both sexes, and among adults who died above and below 65y of age.
Cardio-vascular diseases
Ischemic heart disease, stroke, and other, unspecified cardiac and vascular disease
(all area total of 1,384 deaths; 595 [43%] male, 798 female). The median age of
death for CVDs was 73y (IQR 59-81; Figure 5), with one third of CVD-attributed
deaths among adults,65y of age. Males were more likely than females to die from
CVDs before the age of 65y (39% v 31%, respectively, x2 9.4, p50.002).
Among 1,170 CVD deaths assessed for trends over time (excluding Karemo),
deaths fell marginally from 141 to 127 between 2003 and 2010 apart from a spike
in deaths in 2008 (Table S2, Figure S3). This was in parallel with the overall fall in
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deaths from NCD causes, resulting in a steady relative contribution of CVDs to a
quarter of all NCD deaths (2003–25%; 2010–27%).
(i) Ischemic heart disease (100 deaths): This category is limited to angina
pectoris, myocardial infarction and, acute and chronic ischemic heart disease.
These constituted 7% of all CVD deaths, 9% of all male and 6% of all female
CVD deaths. The median age at death for was 69y (IQR 55-78) with 36%
aged ,65y old. The number of deaths attributed to these diseases did not
increase over time.
(ii) Stroke (327 deaths): This includes cerebral haemorrhage, occlusions,
infarctions and other cerebrovascular disease and sequelae. These represented
24% of all CVD deaths, 24% for male and for female CVD deaths. The
median age at death for stroke was 70y (IQR 56-79) with 42% of deaths in
adults aged ,65y. The number of deaths attributed to stroke did not increase
over time.
(iii) Other/unspecified cardiac and vascular diseases (957 deaths): This category
comprises a broad range of circulatory and hypertensive disorders. These
represent 69% of all CVD deaths. The median age at death for other/
unspecified cardiac and vascular disease was 74y (IQR 61-81) with 32% of
deaths occurring among adults ,65y. Overall, the absolute number of deaths
from these diseases varied over time, with a spike in 2008. There was a
significant increase in adults>65y (x2 LT: males 16.2, p,0.001; females 14.7,
p,0.001).
Abdominal diseases
Acute abdomen or liver cirrhosis (all area total of 760 deaths; 411 [54%] male, 349
female). The median age of death for abdominal disease was 61y (IQR 38-76;
Figure 5). Over half (55%) of deaths were in adults aged ,65y of age at death.
Among 680 deaths attributed to abdominal disease assessed for trends over
time (excluding Karemo), deaths fell 4-fold over time; from 113 reported in 2003,
to 32 deaths in 2010 (Table S3, Figure S4). This decreased the relative
contribution of deaths from abdominal diseases to all NCD deaths from 20% to
7% (x2 LT 78, p,0.001).
(i) Acute abdomen (635 deaths): This was recorded in 84% of deaths from
abdominal disease, equally for males and females. The median age at death for
abdominal disease was 58y (IQR 35-75), with 59% occurring among adults
aged ,65y. The absolute number of deaths ascribed to acute abdomen
decreased among younger aged adults over time, particularly among females.
(ii) Liver cirrhosis (125 deaths): This includes alcoholic liver disease, toxic liver
disease, hepatic failure and chronic hepatitis, not elsewhere classified, liver
fibrosis/cirrhosis, inflammatory or other liver diseases. These represented 16%
of deaths from abdominal disease, with a similar proportion in both sexes.
The median age at death for liver cirrhosis was 71y (IQR 56-81) with 37% of
adults ,65y of age. The number of deaths attributed to liver cirrhosis also fell
over time.
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Pulmonary disease
Asthma, chronic or obstructive pulmonary disease (all area total of 231 deaths;
111 [48%] male, 121 female). The median age of death for pulmonary disease was
75y (IQR 59-82; Figure 5). Less than a third (31%) of deaths were among adults
aged ,65y.
Among 167 deaths attributed to pulmonary disease assessed for trends over
time (excluding Karemo), deaths rose from 4 in 2003 to 36 in 2010 (Table S4,
Figure S6). The contribution of pulmonary disease deaths to NCD deaths thus
increased from ,1% to 8% (x2 LT 66, p,0.001).
(i) Asthma was contributed 39% of pulmonary disease deaths, with a median age
at death of 64y (IQR 42-78) and half of deaths occurring among adults aged
,65y.
(ii) Other chronic or obstructive pulmonary disease included bronchitis,
emphysema, and other chronic obstructive pulmonary disease contributing
61% of the pulmonary disease deaths, with a similar proportion in both sexes.
The median age at death was 78y (IQR 70-85) with 18% occurring in adults
aged ,65y. Significantly fewer males were ,65y (10%) compared with
females (27%; p50.01).
Diseases of the metabolism
Includes diabetes mellitus, severe anaemia, and severe malnutrition (all area total
of 216 deaths; 123 [57%] male, 93 female). The median age of death for diseases of
the metabolism was 70y (IQR 57-79; Figure 5). Over one third (39%) of deaths
attributed to metabolic disorders were among person aged ,65y.
Among 198 deaths attributed to metabolic causes assessed for trends over time
(excluding Karemo), deaths fell from 6% to 2% of NCD deaths between 2003 and
2010 (Table S3, Figure S5).
(i) Diabetes mellitus (136 deaths): This contributed 63% of deaths attributed to
metabolic causes; 74% of metabolic deaths among males and 48% among
females. The median age at death for diabetes mellitus was 72y (IQR 61-79),
with 33% of deaths among adults aged below 65y. The number of deaths
attributed to diabetes was sporadic over time.
(ii) Severe malnutrition (39 deaths): This contributed 18% of deaths attributed
to metabolic causes. The median age at death for severe malnutrition was 63y
(IQR 43-79). While 93% of male malnutrition deaths died ,65y of age,
among females this was distributed across the age range.
(iii) Severe anaemia (41 deaths): 19% of deaths attributed to metabolic causes
were ascribed to severe anaemia. The median age at death for severe anaemia
was 68y (IQR 51-79), with 39% ,65y of age.
Renal disease
Acute kidney failure, chronic kidney disease, unspecified kidney failure (all area
total of 118 deaths; 73 [62%] male, 45 female). The median age of death for renal
Non-Communicable Disease Deaths in Rural Kenya
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disease was 72y (IQR 64-83; Figure 5); 28% of deaths were adults ,65y of age,
and was similar between sexes.
Among 108 deaths attributed to renal disease assessed for trends over time
(excluding Karemo), deaths fell from 4% to 2% of NCD deaths (Table S4, Figure
S7).
Epilepsy
(All area total of 32 deaths; 21 [66%] male, 11 female.) The median age of death
attributed to epilepsy was 24y (IQR 19-35; Figure 5). Nearly all (97%) deaths were
among adults ,65y of age. Deaths attributed to epilepsy were constant over time,
contributing ,,1% of NCD deaths (Table S4, Figure S8).
Other/unspecified NCDs
Includes disorders of prostate, mental and behavioural, and degenerative
musculoskeletal connective disorders (all area total of 404 deaths; 188 [47%] male,
216 female). The median age of death for all other/unspecified NCDs was 70y
(IQR 47-80; Figure 5). Just under half (45%) of deaths were among adults aged
,65y. The age difference by sex was significant with a median age among males of
59y (IQR 40-77), compared with females of 73y (IQR 50-82).
Among 345 deaths attributed to all other and unspecified NCDs assessed for
trends over time (excluding Karemo; Table S3, Figure S9), deaths fell from 12% to
6% of NCD deaths (x2 LT 21.4, p,0.001).
Annual NCD Mortality Rates
NCD mortality rates between 2003 and 2010 showed significant trends by sex, age
(15y to 65y or >65y) threshold, and against CD mortality rates. Trends in
mortality rates ascribed to the main NCD causes of death; cancers, CVDs, and
abdominal diseases were examined in greater detail.
Overall NCD Mortality Rates
Mortality rates (MRs) varied by year, with a modest overall reduction between
2003 (713 per 100,000) and 2010 (563 per 100,000; x2 LT 4.2, p50.04; Table 1).
NCD MRs were consistently higher among males than females. While NCD MRs
among males fell significantly from 800 to 597 per 100,000 (x2 LT 5.8, p50.02),
the fall from 644 to 536 per 100,000 among females was not significant (p50.32).
These trends comprise a significant rise in NCD MRs among both males and
females in persons aged >65y, in tandem with very significant reductions in NCD
MRs in both males and females aged ,65y (Table 1). NCD MRs peaked in 2008,
with an approximate 25% increase above the previous and subsequent year for
both sexes.
Comparison between NCD and CD Annual Mortality Rates (MRs)
Among males, CD MRs were significantly higher than NCD MRs each year and
overall (Table 2). MRs for both CDs and NCDs both reduced over time, but
dropped more for CDs than for NCDs. While the CD MR for females was,2-fold
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higher than for NCDs in 2003, by 2010 rates had fallen to an equivalent level (RR
1.11, 0.93–1.32, p50.25, Table 3). Among older males, MRs between CDs and
NCDs were not significantly different (Table 2). Among older females, MRs for
NCD rose, but fell for CD over time resulting in a significantly higher MR for
NCD by 2010 (Table 3). For deaths among adults aged ,65y, the comparison
between CD and NCD MRs over time shows sharp falls for both CDs and NCDs.
Among males and females, both CD and NCD MRs fell ,2-fold (Tables 2, 3).
While the MR for NCDs was unusually high in 2008, this was not evident for CDs.
Table 1. NCD Mortality Rates per 100,000 adult population by sex and 65 year old age threshold by year.
Mortality Rates Ratio
Male Female RRmale (95% CI) x2 p value F/M
All 2003 800 644 1.24 (1.05–1.47) 6.4 0.011 0.8
2004 705 584 1.21 (1.01–1.44) 4.3 0.039 0.8
2005 731 523 1.40 (1.17–1.68) 13.4 ,0.001 0.7
2006 805 653 1.23 (1.04–1.45) 6.1 0.013 0.8
2007 591 597 0.99 (0.82–1.19) 0.0 0.91 1.0
2008 848 750 1.13 (0.97–1.32) 2.4 0.12 0.9
2009 678 557 1.22 (1.02–1.45) 4.9 0.028 0.8
2010 597 536 1.12 (0.93–1.34) 1.4 0.24 0.9
x2 LT 5.8 0.32 MHRR 1.19 (1.12–1.26)
p value 0.016 0.57 Summary x2 30.1; p,0.001
,65y 2003 517 409 1.26 (1.01–1.58) 4.2 0.04 0.8
2004 381 285 1.36 (1.03–1.74) 4.7 0.03 0.7
2005 417 263 1.58 (1.22–2.06) 11.9 ,0.001 0.6
2006 447 285 1.57 (1.22–2.02) 12.6 ,0.001 0.6
2007 320 250 1.28 (0.97–1.69) 3.1 0.08 0.8
2008 478 325 1.47 (1.16–1.85) 10.7 0.001 0.7
2009 262 188 1.39 (1.02–1.90) 4.5 0.035 0.7
2010 283 183 1.55 (1.14–2.11) 8.0 0.005 0.6
x2 LT 22.89 30.69 MHRR 1.42 (1.30–1.56)
p value ,0.001 ,0.001 Summary x2 56; p,0.001
>65y 2003 3262 2407 1.35 (1.05–1.75) 5.5 0.019 0.7
2004 3528 2802 1.26 (0.99–1.60) 3.6 0.059 0.8
2005 3527 2368 1.49 (1.16–1.96) 10.1 0.002 0.7
2006 4164 3356 1.24 (1.00–1.55) 3.7 0.054 0.8
2007 3144 3069 1.02 (0.81–1.30) 0.0 0.84 1.0
2008 4435 3867 1.15 (0.93–1.41) 1.7 0.19 0.9
2009 4815 3282 1.47 (1.19–1.81) 12.9 ,0.001 0.7
2010 3680 3123 1.18 (0.94–1.48) 2.0 0.16 0.8
x2 LT 6.7 14 MHRR 1.26 (1.16–1.36)
p value 0.01 ,0.001 Summary x2 30.9; p,0.001
Note:
Mortality rates 2003–2010 exclude villages added to the study site (Karemo) 2008–2010.
LT: linear trend 2003–2010; MHRR: Mantel Haenszel Relative Risk.
doi:10.1371/journal.pone.0114010.t001
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Annual Mortality Rates for top three NCD causes
Cancer MRs increased from 200 to 262 per 100,000 population (x2 LT 22.1,
p,0.001; Table 4); with a significant rise for both sexes. This trend reflected rising
rates among those >65y in males and females, with the MR in 2010 over 2-fold
higher than in 2003. Conversely cancer MRs among adults ,65y of age declined
(except in 2008). Males had significantly higher cancer MRs than females on
aggregate and by age category (Table 4). Most notable among cancers was the rise
in respiratory/intrathoracic cancers which rose numerically and by percentage of
Table 2. Male CD and NCD Mortality Rates per 100,000 adults by 65 year old age threshold by year.
Mortality Rates Ratio
CD NCD RRCD (95% CI) x2 p value NCD/CD
All 2003 1461 800 1.83 (1.57–2.12) 64 ,0.001 0.5
2004 1481 705 2.10 (1.80–2.45) 93 ,0.001 0.5
2005 1351 731 1.85 (1.58–2.15) 63 ,0.001 0.5
2006 1296 805 1.61 (1.39–1.87) 40 ,0.001 0.6
2007 1014 591 1.72 (1.45–2.04) 39.6 ,0.001 0.6
2008 908 848 1.07 (0.92–1.25) 0.76 0.38 0.9
2009 1063 678 1.57 (1.34–1.84) 31 ,0.001 0.6
2010 777 597 1.30 (1.09–1.55) 8.6 0.003 0.8
x2 LT 129 5.8 MHRR:1.61 (1.53–1.71)
p value ,0.001 0.016 Summary x2 292; p,0.001
,65y 2003 1285 517 2.48 (2.06–2.99) 98 ,0.001 0.4
2004 1327 381 3.48 (2.83–4.29) 158 ,0.001 0.3
2005 1214 417 2.91 (2.38–3.56) 120 ,0.001 0.3
2006 1052 447 2.35 (1.93–2.87) 76 ,0.001 0.4
2007 816 320 2.55 (2.03–3.20) 69 ,0.001 0.4
2008 763 478 1.59 (1.31–1.94) 21.7 ,0.001 0.6
2009 902 262 3.44 (2.71–4.37) 116 ,0.001 0.3
2010 646 283 2.28 (1.79–2.91) 47 ,0.001 0.4
x2 LT 126.5 22.89 MHRR:2.57 (2.38–2.76)
p value ,0.001 ,0.001 Summary x2 672; p,0.001
>65y 2003 2997 3262 0.92 (0.71–1.20) 0.39 0.53 1.1
2004 2828 3528 0.80 (0.62–1.04) 2.7 0.1 1.2
2005 2565 3527 0.73 (0.55–0.95) 5.4 0.02 1.4
2006 3591 4164 0.86 (0.68–1.10) 1.46 0.23 1.2
2007 2877 3144 0.92 (0.70–1.20) 0.41 0.52 1.1
2008 2320 4435 0.52 (0.40–0.68) 23.3 ,0.001 1.9
2009 2665 4815 0.55 (0.43–0.71) 21.2 ,0.001 1.8
2010 2065 3680 0.56 (0.42–0.75) 15.6 ,0.001 1.8
x2 LT 5.8 6.7 MHRR:0.72 (0.65–0.79)
p value 0.16 0.01 Summary x2 49; p,0.001
Note:
Mortality rates 2003–2010 exclude villages added to the study site (Karemo) 2008–2010.
LT: linear trend 2003–2010; MHRR: Mantel Haenszel Relative Risk.
doi:10.1371/journal.pone.0114010.t002
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all cancers over time. The MRs for CVDs did not differ significantly by sex, and
showed no change over time, overall, by sex, or by age category (Table 5). CVD
MRs in 2008 appeared aberrant with a doubling of MRs in adults,65y, compared
with 2007 and 2009. MRs for abdominal disease decreased more than 3-fold in
both sexes; this was evident in both younger and older populations (Table 6).
MRs were significantly higher in males overall, and by age threshold, but varied in
magnitude between years. There was no evidence of a rise in the abdominal
diseases MR in 2008.
Table 3. Female CD and NCD Mortality Rates per 100,000 adults by 65 year old age threshold by year.
Mortality Rates Ratio
CD NCD RRCD (95% CI) x2 p value NCD/CD
All 2003 1266 644 1.97 (1.70–2.28) 86 ,0.001 0.5
2004 1405 584 2.40 (2.07–2.79) 114 ,0.001 0.4
2005 1337 523 2.56 (2.19–2.99) 153 ,0.001 0.4
2006 1344 653 2.06 (1.78–2.37) 103 ,0.001 0.5
2007 1074 597 1.80 (1.55–2.09) 60 ,0.001 0.6
2008 886 750 1.18 (1.02–1.36) 5.09 0.024 0.8
2009 832 557 1.49 (1.27–1.75) 24.5 ,0.001 0.7
2010 594 536 1.11 (0.93–1.32) 1.34 0.25 0.9
x2 LT 206 0.32 MHRR:1.79 (1.70–1.89)
p value ,0.001 0.57 Summary x2 476; p,0.001
,65y 2003 1208 409 2.95 (2.47–3.60) 147 ,0.001 0.3
2004 1353 285 4.75 (3.86–5.86) 261 ,0.001 0.2
2005 1230 263 4.67 (3.76–5.81) 234 ,0.001 0.2
2006 1229 285 4.32 (3.50–5.33) 223 ,0.001 0.2
2007 999 250 4.00 (3.20–5.01) 172 ,0.001 0.3
2008 817 325 2.51 (2.05–3.08) 84 ,0.001 0.4
2009 685 188 3.65 (2.82–4.72) 112 ,0.001 0.3
2010 505 183 2.76 (2.11–3.62) 60 ,0.001 0.4
x2 LT 221.1 30.69 MHRR:3.66 (3.39–3.95)
p value ,0.001 ,0.001 Summary x2 1270; p,0.001
>65y 2003 1699 2407 0.71 (0.54–0.93) 6.16 0.013 1.4
2004 1789 2802 0.64 (0.49–0.83) 11.5 ,0.001 1.6
2005 2101 2368 0.89 (0.69–1.14) 0.86 0.35 1.1
2006 2185 3356 0.65 (0.51–0.82) 13 ,0.001 1.5
2007 1609 3069 0.52 (0.41–0.68) 24.9 ,0.001 1.9
2008 1388 3867 0.36 (0.28–0.47) 64.9 ,0.001 2.8
2009 1913 3282 0.58 (0.46–0.74) 19.8 ,0.001 1.7
2010 1246 3123 0.40 (0.30–0.53) 47.4 ,0.001 2.5
x2 LT 5.3 14 MHRR:0.57 (0.52–0.62)
p value 0.02 ,0.001 Summary x2 152; p,0.001
Note:
Mortality rates 2003–2010 exclude villages added to the study site (Karemo) 2008–2010.
LT: linear trend 2003–2010; MHRR: Mantel Haenszel Relative Risk.
doi:10.1371/journal.pone.0114010.t003
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Discussion
While global studies highlight the potential growing burden of NCDs in LMIC,
relatively few data from LMIC have been published [13]. Our study provides
insights into the mortality burden of NCDs in adults in a rural African
community. We found over a third of adult deaths were attributed to NCDs. This
is similar to the INDEPTH international network which attributed 34.8% of
Table 4. Cancer Mortality Rates per 100,000 population by sex by 65y age threshold by year.
Mortality Rates %Respiratory Ca
Male Female Total RRmale (95% CI) x2 p value Male Female
All 2003 249 162 200 1.54 (1.12–2.12) 7.04 0.008 6.1 2.9
2004 237 151 189 1.56 (1.13–2.18) 7.22 0.007 6.3 7.8
2005 242 158 195 1.53 (1.11–2.12) 6.84 0.009 13.4 9.0
2006 256 225 239 1.14 (0.85–1.52) 0.77 0.38 14.8 15.6
2007 142 159 151 0.89 (0.62–1.28) 0.38 0.54 8.0 10.1
2008 307 280 292 1.10 (0.85–1.42) 0.52 0.47 29.5 31.7
2009 318 224 266 1.42 (1.09–1.86) 6.76 0.009 42.6 41.0
2010 290 239 262 1.22 (0.93-1.59) 2.04 0.15 55.2 44.9
x2 LT 52.4 18.76 22.07 MHRR 1.27 (1.15–1.41)
p value 0.022 ,0.001 ,0.001 Summary x2 20.69; p,0.001
,65 2003 196 105 145 1.87 (1.25–2.80) 9.4 0.002 6.9 2.6
2004 144 78 107 1.85 (1.15–2.96) 6.7 0.01 2.3 3.4
2005 157 94 123 1.68 (1.08–2.59) 5.5 0.02 4.2 5.7
2006 154 114 133 1.35 (0.89–2.03) 2 0.15 10.4 9.3
2007 91 110 102 0.82 (0.51–1.32) 0.6 0.42 3.4 11.9
2008 188 144 164 1.30 (0.91–1.87) 2.1 0.15 27.4 33.3
2009 119 66 90 1.80 (1.10–2.96) 5.6 0.018 38.5 50.0
2010 140 81 108 1.73 (1.10–2.71) 5.8 0.016 52.2 40.6
x2 LT 2.8 0.17 2.2 MHRR 1.50 (1.29–1.74)
p value 0.09 0.68 0.14 Summary x2 27; p,0.001
>65 2003 705 587 635 1.20 (0.70–2.06) 0.45 0.5 4.2 3.4
2004 1050 696 839 1.51 (0.95–2.40) 3.07 0.08 11.1 11.4
2005 991 611 762 1.62 (1.00–2.62) 3.96 0.047 26.5 12.5
2006 1207 1034 1102 1.17 (0.78–1.76) 0.55 0.46 20.0 20.8
2007 623 505 551 1.23 (0.70–2.18) 0.52 0.47 14.3 7.4
2008 1468 1277 1351 1.15 (0.80–1.65) 0.58 0.45 32.0 30.4
2009 2302 1388 1737 1.66 (1.21–2.28) 9.97 0.002 44.7 37.8
2010 1765 1394 1537 1.27 (0.90–1.78) 1.88 0.17 57.6 46.7
x2 LT 33.75 37.5 70.7 MHRR 1.35 (1.17–1.56)
p value ,0.001 ,0.001 ,0.001 Summary x2 16.4; p,0.001
Note:
Mortality rates 2003–2010 exclude villages added to the study site (Karemo) 2008–2010.
LT: linear trend 2003–2010; MHRR: Mantel Haenszel Relative Risk.
%Respiratory Ca– the proportion of respiratory cancer deaths among all cancer deaths by year and sex.
doi:10.1371/journal.pone.0114010.t004
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deaths, ascribed by verbal autopsy, in 21 health and demographic surveillance sites
in Africa and Asia to NCD [33]. A proportionate rise in NCDs over the
surveillance period (2003 to 2010) was due to a significant increase among older
adults (aged >65y), but was accompanied by a fall in overall NCD mortality rates
among persons ,65y of age. The latter appears to be in parallel to HIV-associated
mortality reductions. In both age groups, annual NCD mortality rates were
significantly higher in males. Over a third (36%) of all NCD deaths were
Table 5. Cardio-Vascular Disease Mortality Rates per 100,000 population by sex by 65y age threshold by year.
Mortality Rates % other CVDs
Male Female Total RRmale (95% CI) x2 p value Male Female
All 2003 191 185 188 1.03 (0.74–1.44) 0.03 0.86 46.0 59.0
2004 168 189 180 0.89 (0.63–1.25) 0.47 0.49 48.2 53.8
2005 165 151 157 1.10 (0.77–1.57) 0.25 0.62 50.0 56.3
2006 163 194 180 0.84 (0.60–1.18) 1.06 0.3 66.1 56.6
2007 139 207 177 0.67 (0.47–0.95) 5.15 0.023 71.4 68.9
2008 255 260 258 0.98 (0.75–1.29) 0.02 0.88 83.9 87.2
2009 169 217 195 0.78 (0.57–1.07) 2.36 0.12 80.3 86.6
2010 155 158 157 0.98 (0.69–1.39) 0.02 0.9 73.2 67.6
x2 LT 0 1.089 0.64 MHRR 0.90 (0.80–1.01)
p value 0.99 0.3 0.43 Summary x2 3.17; p50.075
,65 2003 91 116 105 0.79 (0.49–1.28) 1 0.33 40.7 53.5
2004 74 59 66 1.24 (0.69–2.25) 0.5 0.47 31.8 45.5
2005 72 43 56 1.68 (0.88–3.20) 2.6 0.11 27.3 50.0
2006 68 61 64 1.10 (0.61–1.99) 0.1 0.74 61.9 65.2
2007 50 47 49 1.06 (0.54–2.08) 0 0.86 50.0 55.6
2008 118 98 107 1.20 (0.77–1.87) 0.7 0.42 79.5 84.6
2009 58 81 71 0.71 (0.40–1.26) 1.4 0.24 89.5 81.3
2010 64 53 58 1.20 (0.66–2.20) 0.4 0.55 61.9 76.2
x2 LT 0.52 0.91 1.4 MHRR 1.06 (0.87–1.29)
p value 0.47 0.34 0.24 Summary x2 0.3; p50.57
>65 2003 1058 708 851 1.49 (0.94–2.37) 2.92 0.09 50.0 65.7
2004 991 1153 1087 0.86 (0.56–1.31) 0.49 0.48 58.8 56.9
2005 991 917 946 1.08 (0.70–1.67) 0.12 0.73 64.7 58.3
2006 1056 1171 1126 0.90 (0.60–1.37) 0.24 0.63 68.6 53.3
2007 979 1347 1205 0.73 (0.48–1.09) 2.36 0.12 81.8 72.2
2008 1586 1443 1498 1.10 (0.78–1.55) 0.29 0.59 87.0 88.5
2009 1272 1219 1239 1.04 (0.71–1.53) 0.05 0.83 76.2 89.2
2010 1047 930 975 1.13 (0.73–1.73) 0.3 0.59 80.0 64.0
x2 LT 1.69 3.5 5.15 MHRR 1.01 (0.87–1.17)
p value 0.19 0.06 0.023 Summary x2 0.01; p50.92
Note:
Mortality rates 2003–2010 exclude villages added to the study site (Karemo) 2008–2010.
LT: linear trend 2003–2010; MHRR: Mantel Haenszel Relative Risk.
% other CVDs – the proportion of other/unspecified CVDs deaths among all CVDs deaths by year and sex.
doi:10.1371/journal.pone.0114010.t005
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attributed to cancers, with a significant increase in deaths attributed to respiratory
neoplasms. CVD was the second most common cause, responsible for 29% of
deaths, although our data found no evidence of a rise in mortality rates in this
surveillance period.
Verbal autopsy and the use of interVA-4 software have enabled a systematic
classification of cause of death over time in the HDSS. These data document the
important and growing contribution of NCDs to mortality in rural African
Table 6. Abdominal Disease Mortality Rates per 100,000 population by sex by 65y age threshold by year.
Mortality Rates % Liver Disease
Male Female Total RRmale (95% CI) x2 p value Male Female
All 2003 146 154 150 0.94 (0.65–1.37) 0.1 0.76 20.8 15.4
2004 153 132 141 1.15 (0.79–1.69) 0.55 0.46 13.7 17.9
2005 168 111 136 1.52 (1.02–2.23) 4.57 0.032 28.1 12.8
2006 166 112 136 1.47 (1.00–2.16) 3.98 0.046 10.5 25.0
2007 150 115 131 1.31 (0.89–1.92) 1.84 0.17 22.6 18.0
2008 121 64 90 1.87 (1.17– 7.14 0.008 11.4 24.1
2009 83 29 53 2.86 (1.49–5.48) 10.95 ,0.001 10.0 15.4
2010 47 33 40 1.40 (0.70–2.81) 0.93 0.34 5.9 6.7
x2 LT 23.91 63.03 80.9 MHRR 1.38 (1.19–1.61)
p value ,0.001 ,0.001 ,0.001 Summary x2 17.61; p,0.001
,65 2003 98 113 106 0.87 (0.54–1.39) 0.4 0.55 13.8 7.1
2004 87 89 88 0.98 (0.59–1.64) 0 0.94 7.7 3.0
2005 105 73 87 1.45 (0.87–2.42) 2 0.15 28.1 11.1
2006 100 53 74 1.87 (1.07–3.29) 5 0.03 3.2 20.0
2007 94 55 73 1.71 (0.98–2.98) 3.6 0.06 10.0 14.3
2008 97 35 63 2.74 (1.46–5.14) 11 0.001 12.5 28.6
2009 40 15 26 2.60 (0.99–6.84) 4 0.04 0.0 33.3
2010 30 15 22 2.00 (0.73–5.11) 1.9 0.17 10.0 0.0
x2 LT 2.8 55.5 58.9 MHRR 1.47 (1.20–1.80)
p value 0.09 ,0.001 ,0.001 Summary x2 13; p,0.001
>65 2003 558 465 503 1.20 (0.65–2.20) 0.35 0.56 31.6 30.4
2004 729 457 567 1.59 (0.91–2.80) 2.67 0.102 20.0 39.1
2005 729 382 519 1.91 (1.06–3.42) 4.82 0.028 28.0 15.0
2006 785 546 640 1.44 (0.84–2.44) 1.8 0.18 19.2 28.6
2007 682 543 597 1.26 (0.73–2.17) 0.68 0.41 39.1 20.7
2008 352 278 306 1.27 (0.60–2.71) 0.38 0.54 8.3 20.0
2009 515 131 278 3.92 (1.63–9.45) 10.82 0.001 17.6 0.0
2010 209 167 183 1.25 (0.47–3.36) 0.2 0.65 0.0 11.1
x2 LT 7.94 13.99 20.65 MHRR 1.54 (1.23–1.92)
p value 0.005 ,0.001 ,0.001 Summary x2 14.02; p,0.001
Note:
Mortality rates 2003–2010 exclude villages added to the study site (Karemo) 2008–2010.
LT: linear trend 2003–2010; MHRR: Mantel Haenszel Relative Risk.
% Liver Disease – proportion of liver disease deaths to all deaths attributed to abdominal disease by year and gender.
doi:10.1371/journal.pone.0114010.t006
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communities. While CDs have historically dominated public health concerns in
LMICs, data presented here show that NCDs constitute probable cause of death in
close to four in every ten adult deaths. In contrast, an estimated 80% of the health
budgets in sub-Saharan African countries are allocated to acute CDs [34]. While
the latter includes diagnosis and treatment of communicable diseases among
children, Morhason-Bello and colleagues nevertheless argue the need for a
substantial increase in investment for cancer care in Africa [34]. In our study, the
ratio of NCDs to CDs among adults increased significantly between 2003 and
2010. This reflects the steady reduction in deaths from HIV/AIDS [21,26], as well
as a concomitant increase in rates of death from neoplasms among persons aged
>65y. A third of NCD deaths were among younger adults ,65 years of age, often
referred to as premature – and largely preventable – deaths. A 2-fold reduction of
NCD deaths was observed in this younger age group, which paralleled a reduction
in the annual mortality rates for CDs, and was largely due to the reduction in
deaths in adults ,65 years attributed to cancers. Another trend of note was the
spike in NCD deaths (notably CVD) in 2008, occurring in both sexes and both age
groups. The only known change in this population was election violence causing
additional migration, and interruptions to health care access and services during
2008 [24]. Indeed, HIV deaths among adults were found to rise perhaps reflecting
an interruption in HIV treatment availability [35]. A similar spike in deaths
among children under 5 years of age was assumed to be related to antimalarial
‘stock-outs’ at local health facilities although the role of post-election violence in
the stock-outs or in childhood mortality overall could not be ruled out [25]. The
spike in NCDs suggests a broader influence, deserving attention.
Neoplasms were responsible for over a third (35%) of all NCD deaths; the 41%
rise between 2003 and 2010 was, as noted above, due to a sharp rise in persons
aged.65y. The proportion of cancers appears to be considerably higher than that
reported nationally in Kenya (where cancer-related deaths account for half that
compared with CVD related deaths) [36]. This may partly reflect differing risk
from exposures in rural western Kenya compared with urban environments. It
more likely also reflects a difference in selection as only registered causes of death
are included in the Kenyan cancer registry [36], underrepresenting deaths at home
or in the community, and cause attribution (i.e. registered cause of death vs. that
assigned by verbal autopsy and InterVA).
Until relatively recently, cancer was poorly recognised as a public health priority
in African countries, particularly in areas with a high burden of CDs such as HIV,
TB and malaria. Concern has now been raised that cancers are an emerging public
health problem in Africa, with 715,000 new cases and 542,000 deaths estimated in
2008 [37]. In Kenya, the government has made NCDs a national priority [38], and
has developed a cancer registry [39]. This will likely have increased public
awareness, although permeation into rural communities may be somewhat less
than urban settlements. In 2006, around 2 354 women were diagnosed with
cervical cancer and 65% of these died of the disease [39]. Accepting the many
caveats surrounding our study, our data support the need for increased focus on
NCDs, especially among populations now aging due to reductions in early deaths
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from HIV-related diseases, and common childhood illnesses. Thus, there is an
urgent need for increased attention to improve cancer screening, diagnosis and
care, and for the development of surveillance systems that capture cancer
diagnosis and deaths [4,6]. Advances in current information and education
services for populations, particularly rural, are required and should encourage
early screening and health care seeking [40]. The continued presence of infectious
diseases that are causally associated with adult malignancies such as HIV, viral
hepatitis and HPV among others; and the increasing life expectancies and
environmental exposures make cancer an increasing problem in SSA, com-
pounded by limited access to appropriate care which can result in low survival
[10].
The fall in cancers among adults aged ,65y reflected the halving of ‘other
neoplasms’ (for both sexes) and a fall in digestive cancers among males. The
category ‘other neoplasms’ includes Kaposi’s sarcoma, which prior to the use of
interVA-4, ascribed HIV as the cause of death and was therefore classified as a CD
[21], but now falls within the NCDs nomenclature. With the increasing coverage
of antiretrovirals, longevity associated with lower HIV (CD) mortality rates
[21,26], will influence NCD cancer deaths. Evidence from Uganda suggests a
higher risk of death in HIV-infected persons compared with non-infected persons
with cancer [41]. Within the study reporting period, we identified 80 persons
whose deaths were attributed to NCDs who were taking antiretroviral treatment at
death, 64% of these were cancer deaths; and among these, 63% were classed as
‘other neoplasms’. This is supported by the Nairobi cancer registry data, which
identifies Kaposi sarcoma to be a leading cancer in males in Kenya [39].
In addition to poverty and poor access to care, and continued exposure to
infectious diseases, the rising cancer burden in SSA is considered to be a
consequence of increasingly westernised lifestyles [42]. Addo and colleagues have
documented a higher prevalence of hypertension in urban compared with rural
settings in SSA, suggesting changing lifestyle factors are responsible [43]. Global
experts have estimated that trends in increased survival, combined with increasing
affluence and access to and exposure to carcinogens such as cigarette smoke will
contribute towards a doubling of neoplasms in LMIC/Africa in the next 20 years
[37]. In our study we noted a substantial rise in respiratory/intrathoracic
neoplasms, with particularly high rates in elders, including females. While rates of
smoking are reportedly low in our study area [44], cultural norms increase risk in
particular age-groups; for example, smoking is more common among older
widowed women (who, since the introduction of ARVs now have a lower risk of
death from HIV [21].) Numerous NCDs including cancers are strongly correlated
with smoking and alcohol [45–48]. In the HDSS, while only 6% of adults reported
they currently smoked and 7% drank alcohol, intensity of exposure among users
was found to be very high, with 60% drinking to excess (drunkenness) on at least
half of all drinking occasions [44]. To date, evaluation of risk behaviours for
NCDs such as inadequate physical activity, poor diet, tobacco smoking, and
alcohol consumption have been minimal, but such data can potentially inform
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preventive programmes. While state of the art cancer care is expensive [34], some
prevention strategies, such as early screening, and policy and environmental
changes that supports individual behaviour change to reduce tobacco smoking
and alcohol consumption [49], as well as non-patent protected chemotherapies
can be affordable [15]. The creation of a package of affordable population
prevention measures for NCD risks will support decision making on the
formulation of preventive strategies and policies in LMICs [11]. The national
cancer control strategy, developed for Kenya, aims to cover the continuum of
prevention and control, promoting cancer prevention, early detection, improve-
ment in diagnosis and treatment, and the promotion of cancer surveillance,
registration and research [38]. Following this, comprehensive management
guidelines have been developed [50].
Many barriers to diagnosis and treatment remain, however, including a lack of
population awareness of symptoms leading to early diagnosis, lack of knowledge
by health workers, lack of chemotherapy and radiotherapy services, and a lack of
suitable pain relief and palliative care [15,34,51–53]. Reduction of exposure to
important pollutants, like smoke from cooking fires inside the home [46], is being
addressed through research studies supported by the Global Alliance for Clean
Cookstoves, including in western Kenya [54,55]. The age of death for some
neoplasms, such as female breast cancers, is young; in our study population
women died at a median age of 41y (IQR 31–47), with 85% of deaths reported
among females ,65y. In Ethiopia, young age and advanced stage have been
associated with poor outcome [56]. This compares with the median age at death
of 68 years in the USA [57]. Lack of treatment may be another component
influencing early death with other contributory factors resulting in more
aggressive forms or accelerating death still to be identified. Cancer Research UK
investigators report black ethnicity is an independent indicator of poor female
breast cancer prognosis among UK women, and note young black women develop
more aggressive tumours with higher recrudescence rates than white women [58].
The contribution of a higher number of pregnancy-associated tumours, identified
in meta-analysis studies to be strongly associated with prognosis [59], is of
relevance to LMICs. Inclusion of prevention awareness programmes in antenatal
care services would further strengthen early diagnosis and treatment opportunities
in this vulnerable population. Global advocacy for implementation of HPV
prevention strategies has gained momentum, with demonstration projects
underway [60].
Globally, deaths from CVDs are expected to rise from 16.7 m to 23.3 m
between 2002 and 2030 [7]. A leading risk factor for CVDs and deaths worldwide
is high blood pressure, with the highest prevalence observed in LMIC [61]. A
systematic review in SSA identified hypertension, excess sodium intake, and low
physical activity, as a major public health issues and called for improved detection,
treatment and control [43]. Further evidence is accumulating of protease
inhibitors increasing the risk of hypertension and obesity among persons under
care for HIV, of substantial importance in regions of high HIV prevalence [62]. In
our rural setting, CVDs accounted for one quarter of all NCDs, with no increase
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detected during the study period. The lack of increase in CVDs may be due to the
relatively low socio-economic status of the predominantly rural population in the
HDSS.
The HDSS infrastructures could be utilized to facilitate intervention studies; for
example, by providing anti-hypertensives and follow-up monitoring to persons
identified to be hypertensive during mass screening at census. Such sentinel sites
also provide opportunities for longitudinal surveillance of key risks such as diet,
smoking and alcohol consumption.
The international community is justly striving for concerted global action with
leadership, prevention, treatment, international cooperation, and monitoring and
accountability proposed as the five overarching priority actions needed to respond
to the global crisis of NCDs [8]. NCDs were defined as a neglected global priority
by member states at the United Nations General Assembly in September 2011 [8],
and the framework for monitoring global progress and a set of global targets to
monitor trends and assess the progress in countries for the prevention and control
of NCDs were adopted at the World Health Assembly in May 2013 [63], along
with a NCDs action plan [64]. Gaps in reporting of NCDs outcomes, and the
accuracy, quality, standardisation of reporting on risk factors previously argued
[65], remains an important consideration however [18,66]. Improving the quality
of risk factor surveillance data is required, particularly in LMICs [6]. A multi-
country study in INDEPTH sites has shown that chronic NCDs risk factor
surveillance is feasible in LMIC settings [67]. There is thus ample opportunity for
HDSS sites to contribute towards this.
Study limitations
We acknowledge a number of caveats when interpreting these data. First,
misclassification between CDs and NCDs, and co-morbidity between diseases may
contribute to the higher proportion of NCD deaths than the 28% estimated
countrywide [36], although higher exposure to CDs may contribute towards a
greater NCD burden. With the substantial improvements in HIV care at least two
scenarios arise: (i) where deaths from HIV mistakenly attributed to NCDs reduce
over time in parallel with reductions in HIV-associated mortality, and (ii) where
deaths caused by NCDs genuinely reduce over time due to the reduction in co-
morbidity from HIV, including Kaposi sarcomas and lymphomas, and other
cancers of viral origin. The correct attribution of cause of death nevertheless
remains a concern in the absence of gold standard comparisons, such as post-
mortem minimally invasive autopsies (MIA), and through prospective clinical
studies. Attention is thus called for to use experience gained to modify tools in use
and to strengthen surveillance systems, to develop robust methodologies that will
remain valuable in the years ahead. Recent evidence suggests the sensitivity and
specificity of computer algorithm based diagnoses such as InterVA-4 is,
nevertheless, an improvement over physician-based ascriptions [32]. We used the
WHO-compliant InterVA-4 (version 4.02) probabilistic model for cause of death
assignments, which has been field tested [31], and is fully compliant with the
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WHO 2012 VA standard and generates causes of death categorised by ICD-10
groups [68]. We note, however that InterVA-4 attribution precludes detailing
specific causes within each ICD-10 category, because any VA method cannot
reveal that level of detail [69]. While the overall estimates currently generated
inform of general NCD trends by ICD-10 category, improved algorithms defining
individual causes would be invaluable for public health programmes. A limitation
of specific causes can lead to misattribution, for example, deaths caused by
complications of diabetes may be attributed to the complication arising, e.g. renal
failure.
Second, we note ascription of cause of death through verbal autopsy depends
on the symptoms reported; symptoms of a chronic disease might have been
reported but for some cases, an underlying disease such as HIV may be
undiagnosed and contribute to cause of death. This is a recognised limitation of
verbal autopsy [33], and supports the need for comparison against other methods
such as MIA. Capture of data retrospectively has a number of limitations,
including recall bias, poor diagnosis due to lack of adequate cancer specialists and
lack of facilities, poor referral and a lack of education both of patient and care
provider. As such, prospective ascertainment would improve the quality of
surveillance should funding be available. Third, although some questions referring
to premorbid clinical symptoms are included in the VA form, the questions are
possibly subject to misinterpretation by family informants. Documentation of
events surrounding death among the elderly may be particularly problematic, for
example, if the informant is an elderly spouse or has little formal education, or
because no next of kin is available and reporting depends on persons with less
knowledge of the individual. Malnutrition as a cause of death among elderly may
be due to underlying disease undiagnosed or miscommunicated to informant
relatives. Attempts are made for timely follow-up to reduce recall bias and
minimise loss of respondents through migration, however. The sharp rise in
deaths attributed to neoplasms, among persons >65y, may partly reflect reporting
bias due to perceptions of the population on the causes of death of older persons.
The rise in respiratory neoplasms reported in this dataset is not mirrored in data
accrued on cancers, through the Kenyan cancer registries, such as the Nairobi
register [39]. In the latter, leading neoplasms recorded are reproductive cancers
such as cervix, breast, and prostate, with few cases of respiratory cancer observed.
Based on 2002 data breast, cervical, and prostate cancers accounted for 23.3%,
20% and 9% of all cancers registered. Such findings have informed policy with the
provision of preventive and treatment guidelines [50,70]. Use of InterVA-4 in 21
HDSS sites across Asia and Africa similarly report higher rates of respiratory
cancer compared with reproductive cancers [33]. This was also true for all three
sites in Kenya (Kilifi, Kisumu, and Nairobi). This may be due to a systematic bias
relating to the capture of information, or may reflect cancer risk of the population
under observation, which may differ from those recorded through current cancer
registries. It is clearly important that further research be conducted to ascertain
the true burden of cancers in both rural and urban communities, including
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through prospective methods, with an expansion of cancer registries to capture
disease burden in rural areas.
Fourth, the significant rise in cancer mortality rates may also reflect
improvement in diagnostic test availability, public perception, or of increased
reporting. We have not identified any obvious systematic bias as a cause for this
rise although capacity in hospitals may be improving, as we have occasional case
reports documenting a confirmatory pathology diagnosis, such as squamous cell
carcinoma in a person who died in the community. Thus, for example, past
respiratory cancers presumptively labeled as TB may now be better detected.
Despite these limitations we believe our data will contribute towards an
understanding of NCDs in LMICs, and will provide a platform for studies
exploring the prevalence, risk factors, and potential interventions to control the
NCD burden in the years ahead.
Conclusion
Data generated from the HDSS in rural western Kenya illustrate the important
contribution of NCDs to adult deaths among rural African communities. Our
data suggest mortality from NCDs are proportionately increasing compared with
CD deaths, with evidence of a rise in the absolute number of deaths from cancer,
and rising mortality rates. Findings presented highlight the need for improve-
ments in prevention, screening, diagnosis, treatment and effectively delivered care
of NCDs and their risk factors [4]. Documentation of risk characteristics in
routine surveillance tools needs to be strengthened to support better epidemio-
logical study and interpretation of the aetiology of NCDs in LMICs, and improve
strategies for prevention of disease.
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